These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 30819002)
1. Elevated Melatonin Levels in Children With Attention Deficit Hyperactivity Disorder: Relationship to Oxidative and Nitrosative Stress. Avcil S; Uysal P; Yenisey Ç; Abas BI J Atten Disord; 2021 Mar; 25(5):693-703. PubMed ID: 30819002 [No Abstract] [Full Text] [Related]
2. Evaluation of Oxidant-Antioxidant Balance in Children with Atopic Dermatitis: A Case-Control Study. Uysal P; Avcil S; Abas Bİ; Yenisey Ç Am J Clin Dermatol; 2016 Oct; 17(5):527-537. PubMed ID: 27417112 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress contribution to attention deficit hyperactivity disorder in children with epilepsy. Elhady M; Youness ER; Mostafa RSI; Abdel Aziz A; Hussein R Appl Neuropsychol Child; 2019; 8(4):347-354. PubMed ID: 30102074 [TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial. Sangouni AA; Mirhosseini H; Hosseinzadeh M Trials; 2022 Oct; 23(1):890. PubMed ID: 36273218 [TBL] [Abstract][Full Text] [Related]
5. Melatonin influences NO/NOS pathway and reduces oxidative and nitrosative stress in a model of hypoxic-ischemic brain damage. Blanco S; Hernández R; Franchelli G; Ramos-Álvarez MM; Peinado MÁ Nitric Oxide; 2017 Jan; 62():32-43. PubMed ID: 27940344 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in children with attention deficit hyperactivity disorder. Oztop D; Altun H; Baskol G; Ozsoy S Clin Biochem; 2012 Jul; 45(10-11):745-8. PubMed ID: 22497926 [TBL] [Abstract][Full Text] [Related]
7. Increased urinary 6-hydroxymelatoninsulfate levels in attention deficit hyperactivity disorder diagnosed children and adolescent. Büber A; Çakaloz B; Işıldar Y; Ünlü G; Bostancı HE; Aybek H; Herken H Neurosci Lett; 2016 Mar; 617():195-200. PubMed ID: 26879834 [TBL] [Abstract][Full Text] [Related]
8. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Spahis S; Vanasse M; Bélanger SA; Ghadirian P; Grenier E; Levy E Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):47-53. PubMed ID: 18757191 [TBL] [Abstract][Full Text] [Related]
9. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Ceylan M; Sener S; Bayraktar AC; Kavutcu M Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1491-4. PubMed ID: 20732373 [TBL] [Abstract][Full Text] [Related]
10. Increased oxidative stress in children with attention deficit hyperactivity disorder. Sezen H; Kandemir H; Savik E; Basmacı Kandemir S; Kilicaslan F; Bilinc H; Aksoy N Redox Rep; 2016 Nov; 21(6):248-53. PubMed ID: 26886057 [TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress. Bulut M; Selek S; Bez Y; Cemal Kaya M; Gunes M; Karababa F; Celik H; Savas HA Psychiatry Res; 2013 Oct; 209(3):638-42. PubMed ID: 23680468 [TBL] [Abstract][Full Text] [Related]
12. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD. Molina-Carballo A; Naranjo-Gómez A; Uberos J; Justicia-Martínez F; Ruiz-Ramos MJ; Cubero-Millán I; Contreras-Chova F; Augustin-Morales MD; Khaldy-Belkadi H; Muñoz-Hoyos A J Psychiatr Res; 2013 Mar; 47(3):377-83. PubMed ID: 23088865 [TBL] [Abstract][Full Text] [Related]
13. Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes. Cubero-Millán I; Molina-Carballo A; Machado-Casas I; Fernández-López L; Martínez-Serrano S; Tortosa-Pinto P; Ruiz-López A; Luna-del-Castillo JD; Uberos J; Muñoz-Hoyos A Int J Mol Sci; 2014 Sep; 15(9):17115-29. PubMed ID: 25257531 [TBL] [Abstract][Full Text] [Related]
14. Homocysteine Levels and Oxidative Stress Parameters in Patients With Adult ADHD. Karababa İF; Savas SN; Selek S; Cicek E; Cicek EI; Asoglu M; Bayazit H; Kandemir H; Kati M; Ulas T J Atten Disord; 2017 Apr; 21(6):487-493. PubMed ID: 24994877 [TBL] [Abstract][Full Text] [Related]
15. Sustained delivery of exogenous melatonin influences biomarkers of oxidative stress and total antioxidant capacity in summer-stressed anestrous water buffalo (Bubalus bubalis). Kumar A; Mehrotra S; Singh G; Narayanan K; Das GK; Soni YK; Singh M; Mahla AS; Srivastava N; Verma MR Theriogenology; 2015 Jun; 83(9):1402-7. PubMed ID: 25805692 [TBL] [Abstract][Full Text] [Related]
16. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Nováková M; Paclt I; Ptáček R; Kuželová H; Hájek I; Sumová A Chronobiol Int; 2011 Aug; 28(7):630-7. PubMed ID: 21859418 [TBL] [Abstract][Full Text] [Related]
17. Kynurenine and oxidative stress in children having learning disorder with and without attention deficit hyperactivity disorder: possible role and involvement. Kilany A; Nashaat NH; Zeidan HM; Hashish AF; El-Saied MM; Abdelraouf ER BMC Neurol; 2022 Sep; 22(1):356. PubMed ID: 36127656 [TBL] [Abstract][Full Text] [Related]
18. Oxidative and Inflammatory Parameters in Children and Adolescents With ADHD. Koç S; Güler EM; Derin S; Gültekin F; Aktaş S J Atten Disord; 2023 Jun; 27(8):880-886. PubMed ID: 36879528 [TBL] [Abstract][Full Text] [Related]
19. Attention Deficit Hyperactivity Disorder and oxidative stress: A short term follow up study. Guney E; Cetin FH; Alisik M; Tunca H; Tas Torun Y; Iseri E; Isik Taner Y; Cayci B; Erel O Psychiatry Res; 2015 Sep; 229(1-2):310-7. PubMed ID: 26188640 [TBL] [Abstract][Full Text] [Related]
20. Effect of melatonin supplementation on oxidative stress parameters: A systematic review and meta-analysis. Morvaridzadeh M; Sadeghi E; Agah S; Nachvak SM; Fazelian S; Moradi F; Persad E; Heshmati J Pharmacol Res; 2020 Nov; 161():105210. PubMed ID: 33007423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]